Stephan Miller

A novel assay to measure calcification propensity: from laboratory to humans

J. Campistol, A. Gold, J. Perelló, 2020, Scientific Reports.

Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.

R. Bagin, H. Dupont, L. Moro, 2014, Journal of travel medicine.

Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis

A. Gold, P. Joubert, J. Perelló, 2019, Journal of Nephrology.

The CALCIPHYX study: a randomized, double-blind, placebo-controlled, Phase 3 clinical trial of SNF472 for the treatment of calciphylaxis

G. Chertow, S. Moe, L. Gould, 2021, Clinical kidney journal.

Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration

J. Buse, R. Pencek, L. Macconell, 2014, Current medical research and opinion.

Enhanced Weight Loss Following Coadministration of Pramlintide With Sibutramine or Phentermine in a Multicenter Trial

L. Aronne, Larry Z. Shen, A. Halseth, 2010, Obesity.

Managing Type 2 Diabetes: Balancing HbA1c and Body Weight

R. Henry, Annie A. Mavian, Stephan Miller, 2010, Postgraduate medicine.

Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis

A. Gold, P. Joubert, J. Perelló, 2019, Journal of Nephrology.